English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Csl Behring
Carol Ostrow
| Dec 16, 2017
CSL partners with Vitaeris for organ transplant therapy
Carol Ostrow
| Sep 29, 2017
CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman
| Apr 18, 2017
CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman
| Apr 14, 2017
CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman
| Apr 12, 2017
CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
Jeff Gantt
| Dec 18, 2016
Afstyla approved by Health Canada
Amanda Rupp
| Jun 22, 2016
CSL Behring honors 2016 HAE Day with events
Amanda Rupp
| Jun 1, 2016
Afstyla gains FDA approval as hemophilia A treatment
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Regulatory
C.D. Marsden
| Apr 18, 2025
FDA Commissioner Makary: 'We are removing industry members—Pharma members—from FDA advisory committees'
